Search Results for: covid-19
Articles
COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine April 7, 2020
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore …..
SGS Digicomply Launches AI System to Find Answers on COVID-19 Within Research Articles April 6, 2020
SGS Digicomply recently announced the launch of a new version of its software dedicated exclusively to the research community and focused on finding….
N4 Pharma Provides Covid-19 Project & Operational Update April 3, 2020
N4 Pharma Plc, the specialist pharmaceutical company developing Nuvec, a novel delivery system for cancer treatments and vaccines, recently announced...Fast New Tests for Covid-19 on the Way April 3, 2020
At present, polymerise chain reaction (PCR) and antibody testing are the dominant ways that global healthcare systems are testing citizens...Saama Makes State-of-the-Art Clinical Analytics Platform Available to Integrate Data From All Organizations Investigating COVID-19 Treatments April 1, 2020
Saama Technologies, Inc. recently announced it will contribute its AI-powered Life Science Analytics Cloud (LSAC) technology platform to establish the EndPandemic National Data Consortium…..
Altimmune & the University of Alabama Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine April 1, 2020
Altimmune, Inc. recently announced it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its single-dose…..
Covid-19 Outbreak in China Threatens Biopharma In-House Manufacturing March 26, 2020
With several mega cap biopharma companies having their vital manufacturing steps in Chinese facilities, the novel coronavirus (Covid-19) outbreak is putting the complicated global biopharma industry’s supply….
Pfizer & BioNTech to Co-develop Potential COVID-19 Vaccine March 18, 2020
Pfizer Inc. and BioNTech SE recently announced the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a….
Biomerica Begins Shipping Samples of 10-Minute Test for COVID-19 Virus Exposure March 18, 2020
Biomerica Inc. recently announced it has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in…..
BeyondSpring Files for Patent Protection on BPI-002 for the Treatment of Viral Infections, Including COVID-19 March 12, 2020
BeyondSpring Inc. recently announced the submission of a provisional US patent application for its pipeline asset BPI-002, for methods of...Beroni Group Advances Research & Development of Medical Solution for Coronavirus (COVID-19) March 12, 2020
Beroni Group recently announced its development of a medical solution using nanobody technology for the novel coronavirus (COVID-19) in collaboration...Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine March 5, 2020
Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) recently announced their partnership to develop a Coronavirus….
Worldwide Research & Collaboration Needed to Combat Covid-19 March 5, 2020
In light of the coronavirus (COVID-19) outbreak, leading data and analytics company GlobalData has analyzed several of the largest COVID-19...Novavax Advances Development of Novel COVID-19 Vaccine February 26, 2020
Novavax, Inc. recently announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19….
IMUNON Announces Positive CMC Meeting With FDA for Advanced Ovarian Cancer Treatment December 19, 2024
IMUNON, Inc. recently announced the positive outcome of a Type C Chemistry, Manufacturing, and Controls (CMC) meeting with the US...EXECUTVE INTERVIEW - Aptar: Advancing Patient-Centric Drug Delivery & Digital Health Solutions December 10, 2024
Gael Touya, President of Aptar Pharma, and Sai Shankar, President, M&A, Strategy, BD, Marketing, Drug Services, Aptar Pharma, discuss the burgeoning potential in the future of pharma and digital health, how the company is a strategic partner to key players in these spaces, and the investments Aptar is making to support the growing demand.
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001 December 10, 2024
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced additional clinical data from ongoing...IMUNON Announces Results From its End-of-Phase 2 Meeting With the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer November 25, 2024
IMUNON, Inc. recently announced the outcome of its recent End-of-Phase 2 in-person meeting with the US FDA, supporting the advancement...HCW Biologics & WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate November 18, 2024
HCW Biologics Inc. and WY Biotech Co., Ltd. recently announced they have entered into a worldwide exclusive license agreement to...Naobios & Sumagen Successfully Optimize HIV Vaccine Candidate for Industrial Production October 29, 2024
Naobios and Sumagen Canada Inc. recently announced the production of the HIV-1 vaccine candidate at bench scale. This key milestone...
